Perceptive Advisors’s AnaptysBio ANAB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q1
Sell
-1,195,336
Closed -$25.7M 142
2020
Q4
$25.7M Buy
+1,195,336
New +$29M 0.28% 76
2020
Q2
Sell
-500,000
Closed -$7.07M 128
2020
Q1
$7.07M Sell
500,000
-500,000
-50% -$7.58M 0.18% 70
2019
Q4
$16.3M Buy
+1,000,000
New +$23.6M 0.32% 55
2018
Q2
Sell
-237,281
Closed -$24.7M 128
2018
Q1
$24.7M Sell
237,281
-519,106
-69% -$58.5M 0.69% 35
2017
Q4
$76.2M Sell
756,387
-225,882
-23% -$16.6M 2.53% 8
2017
Q3
$34.3M Buy
982,269
+30,000
+3% +$809K 1.31% 17
2017
Q2
$22.8M Buy
952,269
+70,312
+8% +$1.77M 1.15% 23
2017
Q1
$24.5M Buy
+881,957
New +$20.5M 1.39% 21

Other funds holding ANAB

Perceptive Advisors's ANAB Position: Q1 2021 in Review

Perceptive Advisors sold out of AnaptysBio (ANAB) in Q1 2021, closing a stake of 1,195,336 shares — an estimated $25.7M sold.

Perceptive Advisors first reported a position in ANAB in Q1 2017 and held it in 8 quarters. The position peaked at $76.2M in Q4 2017. 122 funds tracked by Wall St. Rank hold ANAB as of Q1 2021.

  • Perceptive Advisors reported no remaining AnaptysBio position as of Q1 2021 after selling out during the quarter.
  • Perceptive Advisors sold 1,195,336 AnaptysBio shares in Q1 2021, an estimated $25.7M.
  • Perceptive Advisors first reported a position in AnaptysBio in Q1 2017 and held it in 8 quarters.
  • Perceptive Advisors's AnaptysBio position peaked at $76.2M in Q4 2017.
  • 122 funds tracked by Wall St. Rank held AnaptysBio as of Q1 2021.

Based on Perceptive Advisors's 13F filing for Q1 2021, filed 17 May 2021.